Skip to content

Return on equity at other companies

Abbott logo
AbbottABT
12.4%-18.4pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
13.5%-0.2pp
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
19.1%+1.7pp
Danaher logo
DanaherDHR
7.1%-0.1pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
Fortive logo
FortiveFTV
6.7%-1.0pp

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.1%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.7%
Free cash flow$546.0M

Valuation

See full
Market cap$39.02B-32.0%
Enterprise value$52.71B-29.4%
P/E34.3×-4.0×
P/S1.8×-1.0×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp

Returns & leverage

See full
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Calculated from Becton, Dickinson and Company’s reported figures.

Based on trailing twelve months.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's return on equity?
Becton, Dickinson and Company (BDX) reported return on equity of 4.6% in Q1 2026.
How has Becton, Dickinson and Company's return on equity changed year-over-year?
Becton, Dickinson and Company's return on equity decreased by 21.7% year-over-year, from 5.9% to 4.6%.
What is the long-term trend for Becton, Dickinson and Company's return on equity?
Over 4 years (2021 to 2025), Becton, Dickinson and Company's return on equity has grown at a -5.1% compound annual growth rate (CAGR), from 31.4% to 25.4%.
What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.